SCHEMBL20053172

SCHEMBL20053172

O=C(COC1CCNCC1)N[C@H]1Cc2cccc(C(O)O)c2OB1O

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ ITGB3 P05106 1/20 0.33
▸ ITGA2B P08514 1/20 0.33
▸ PRMT5 O14744 2/20 0.32
▸ WDR77 Q9BQA1 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17457734 0.86 ITGB3 (0.37) ITGB3ITGA2B
SCHEMBL16119478 0.86 ITGB3 (0.37) ITGB3ITGA2B
SCHEMBL20053206 0.79 SMYD3 (0.38) —
SCHEMBL22667379 0.79 NAMPT (0.39) —
SCHEMBL23837376 0.79 SMYD3 (0.34) —
SCHEMBL20370991 0.79 KDM1A (0.32) —
SCHEMBL18797980 0.78 NAMPT (0.35) —
SCHEMBL22667381 0.78 MTNR1A (0.41) —
SCHEMBL15869975 0.78 — —
SCHEMBL19228009 0.77 DRD2 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9944658-B2 Beta-lactamase inhibitors VenatoRx Pharmaceuticals, Inc. (US) 2018-04-17 — — US disclosed
Send feedback